, Singapore

Acromec wins $7m deal to construct lab for Tan Tock Seng Hospital

It also secured an additional $1.8m for after sales maintenance.

Acromec clinched a controlled environment contract for the fitting-out of a Biosafety Level 3 (BSL3) laboratory of the National Centre for Infectious Diseases (NCID), expected to be completed by 2Q17. The total contract deal was $7m. National Centre for Infectious Diseases (NCID) is a facility at the Tan Tock Seng Hospital and was launched in 2014.

To date, Acromec’s order book stands at approximately $49m.

Furthermore, the company has offered an ancillary aftersales maintenance and servicing package, totalling approximately $1.8 million, which will be carried out over the duration of five years.

The option is exercisable by the customer before the defects liability period expires one year from completion.

The company believes the maintenance contract will provide it with a recurring income stream which augments its project-based revenue, while its $7m contract is expected to have a positive impact on its EPS in FY2017. 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare